[Long-term treatment of bronchial asthma with disodiumcromoglycate (Intal) (author's transl)].
26 patients with chronic perennial bronchial asthma were treated with disodiumcromoglycate (Intal). The drug was administered by spinhaler in a daily dose of 4 capsules à 20 mg. There was significant clinical improvement within the first three months of treatment. Airway resistance showed a statistically significant decrease after three months of DSCG treatment. 15 of the 26 patients had been on long-term steroid treatment, in 9 of these 15 patients steroid therapy could be discontinued completely. It is stated that DSCG is effective also in nonallergic bronchial asthma, that there is not only significant clinical improvement, but also functional improvement after three months of DSCG, and that in some steroid dependent asthmatics reduction or complete withdrawal of steroid therapy can be achieved.
D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans
D004205:Cromolyn Sodium
Langzeittherapie des Asthma bronchiale mit Dinatriumcromoglykat (Intal). Klinischer Erfahrungsbericht.